Cytokinetics, Incorporated
Cytokinetics, Incorporated (CYTK) Stock Forecast & Price Predictions
Get the latest Cytokinetics, Incorporated (CYTK) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.
Model Information
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMonthly Forecast
Quarterly Forecast
Yearly Forecast
3 Years Forecast
5 Years Forecast
7 Years Forecast
Cytokinetics, Incorporated Stock Forecast Summary
Cytokinetics, Incorporated (CYTK) stock is currently priced at $67.83. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $57.71.
In the long term, CYTK shows a bearish trend. The 2027 forecast points to $67.69 (-0.21% change), while the 2031 forecast suggests $79.45 (17.13% change). Looking 7 years ahead, projections estimate the stock could trade near $82.14, a 21.09% change from today’s price.
Bearish
Bearish
Bearish
This mix indicates that Cytokinetics, Incorporated stock is expected to trade sideways over the coming years.
Cytokinetics, Incorporated yearly Price Forecast Chart
Explore the yearly forecast chart for CYTK, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Cytokinetics, Incorporated over different timeframes.
No forecast data available
No prediction data found for this time period.
Forecasting data is not available for CYTKForecasting details for CYTK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Cytokinetics, Incorporated Stock Forecast 2026
The forecast for Cytokinetics, Incorporated (CYTK) in 2026 suggests a price of $67.69, representing a -0.21% move from today’s price.
Average Target: $67.69
Market Outlook: bearish based on current trend indicators.
Key Drivers in 2026:- Earnings growth projections.
- Competitive performance in the Healthcare.
- Macroeconomic factors such as interest rates and inflation.
Cytokinetics, Incorporated Stock Forecast 2030
By 2030, Meyka AI projects CYTK could trade near $79.45, showing a potential 17.13% compared to current levels.
Average Target: $79.45
Market Outlook: bullish.
What could influence the 2030 forecast:- Technological innovation and product cycles.
- Expansion into global markets.
- Long-term investor sentiment toward Cytokinetics, Incorporated.
Cytokinetics, Incorporated 7-Year Stock Forecast (2032–2033)
Looking 7 years ahead, the long-term forecast for CYTK points to a price around $82.14, which is a projected 21.09% move from today’s level.
Average Target: $82.14
Outlook: bullish, depending on macroeconomic conditions and sector growth.
Long-Term Drivers:- Global economic expansion or contraction.
- Regulatory and policy environment.
- Cytokinetics, Incorporated’s ability to maintain market leadership.